H. Ishii et al., PREDICTIVE FACTORS FOR RECURRENCE AFTER PERCUTANEOUS ETHANOL INJECTION FOR SOLITARY HEPATOCELLULAR-CARCINOMA, Hepato-gastroenterology, 43(10), 1996, pp. 938-943
Background/Aims: Intrahepatic recurrence frequently occurs in patients
with hepatocellular carcinoma (HCC)even after successful percutaneous
ethanol injection (PEI). This study investigated factors predicting r
ecurrence after PEI for solitary HCC. Materials and Methods: The subje
cts were 31 patients with solitary HCC (10-29 mm) who received success
ful PEI. We investigated the relationship of pretreatment clinicopatho
logical variables to recurrence-free survival including: age, gender,
alcohol abuse, tremor size, tumor staining, tumor differentiation, ser
um alpha-fetoprotein (AFP) level, associated liver disease, and Child-
Pugh classification. Differences in, recurrence-free survival among su
bgroups classified by each factor were evaluated using log-rank tests.
Results: Median recurrence-free survival time, 1 and 2 year recurrenc
e-free survival rates of all 31 patients were 1.57 years, 72.2% and 45
.4%, respectively. Among the 9 variables evaluated, serum AFP Level of
20 ng/ml or less (p <0.005) and absence of cirrhosis (p =0.025) were
factors favoring longer recurrence-free survival significantly. Conclu
sion: These results indicate that HCC patients with higher serum AFP l
evel or coexistent cirrhosis should be followed more closely even afte
r successful PEI.